|
ZNF439 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.286200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.756400E-01 |
| Normal-vs-Stage2 |
3.969600E-01 |
| Normal-vs-Stage3 |
1.037350E-03 |
| Normal-vs-Stage4 |
9.76599999999994E-05 |
| Stage1-vs-Stage2 |
4.480000E-01 |
| Stage1-vs-Stage3 |
3.226200E-04 |
| Stage1-vs-Stage4 |
1.815490E-04 |
| Stage2-vs-Stage3 |
1.614790E-01 |
| Stage2-vs-Stage4 |
4.999800E-02 |
| Stage3-vs-Stage4 |
3.284000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.437500E-02 |
| Normal-vs-AfricanAmerican |
5.221200E-01 |
| Normal-vs-Asian |
5.875000E-01 |
| Caucasian-vs-AfricanAmerican |
4.675200E-01 |
| Caucasian-vs-Asian |
3.122600E-01 |
| AfricanAmerican-vs-Asian |
5.430000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.080200E-02 |
| Normal-vs-Female |
1.117370E-01 |
| Male-vs-Female |
5.724400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.102000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.334000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.575500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.191900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.973800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.094400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.708390E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.390400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.441400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.041500E-02 |
| Normal-vs-Grade 2 |
8.196400E-01 |
| Normal-vs-Grade 3 |
1.018250E-02 |
| Normal-vs-Grade 4 |
7.15959999952887E-07 |
| Grade 1-vs-Grade 2 |
1.251610E-01 |
| Grade 1-vs-Grade 3 |
1.861260E-03 |
| Grade 1-vs-Grade 4 |
7.72600000000789E-05 |
| Grade 2-vs-Grade 3 |
5.939200E-03 |
| Grade 2-vs-Grade 4 |
2.79989999996122E-06 |
| Grade 3-vs-Grade 4 |
6.637800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.051600E-01 |
| Normal-vs-ccB subtype |
1.946200E-02 |
| ccA subtype-vs-ccB subtype |
1.509720E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.513800E-02 |
| Normal-vs-N1 |
1.000000E-02 |
| N0-vs-N1 |
1.969010E-01 |
|
|
